Aveanna Healthcare Holdings Inc.
AVAHHealthcareNASDAQMedical Care Facilities · Last scanned Oct 26, 2026
Scan Results
Daily timeframeAveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. With a market capitalization of $2.92B, it sits in mid-cap territory. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Market Cap
$2.92B
Beta
1.95
P/E (TTM)
10.62
P/E (Fwd)
14.74
EPS (TTM)
$1.26
EPS (Fwd)
$0.91
ROE
198.6%
ROA
9.7%
Cash
$109.2M
Total Debt
$1.51B
Free CF
$103.8M
52W Change
38.9%
Annual Financials
Cash vs Debt
Where AVAH stands vs its 150-day and 200-day moving averages
As of the October 13, 2026 close, AVAH finished 32.72% above its 150-day moving average ($9.20) and 36.73% above its 200-day moving average ($8.93). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is AVAH overbought or oversold?
At the October 13, 2026 close, AVAH's RSI(14) was 28.7, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Aveanna Healthcare Holdings Inc. carries $1.51B in total debt against $109.2M in cash reserves — debt is roughly 13.8x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $103.8M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 198.6% points to exceptionally high capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 9.7% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $1.79B (2022) to $2.43B (2025), reflecting a 36% increase over the period.
Aveanna Healthcare Holdings Inc.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing AVAH.